home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
C4 Therapeutics to Present at the 3rd Annual Targeted Protein Degradation Summit
C4 Therapeutics to Present at the 3rd Annual Targeted Protein Degradation Summit
Post navigation
Previous Post
Previous
PMV Pharma Granted FDA Fast Track Designation of PC14586 for the Treatment of Advanced Cancer Patients that have Tumors with a p53 Y220C Mutation
Next Post
Next
Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causing Proteins